AKAP11 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 1.25100041437065E-10 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
2.31509999948365E-07 |
Normal-vs-Stage2 |
5.322300E-03 |
Normal-vs-Stage3 |
1.27831079055341E-12 |
Normal-vs-Stage4 |
2.41495712316464E-12 |
Stage1-vs-Stage2 |
8.247200E-01 |
Stage1-vs-Stage3 |
4.990000E-04 |
Stage1-vs-Stage4 |
2.997300E-04 |
Stage2-vs-Stage3 |
4.836000E-02 |
Stage2-vs-Stage4 |
2.485800E-02 |
Stage3-vs-Stage4 |
6.034600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
3.13669978879716E-10 |
Normal-vs-AfricanAmerican |
2.38670000429764E-08 |
Normal-vs-Asian |
5.258200E-01 |
Caucasian-vs-AfricanAmerican |
2.716600E-01 |
Caucasian-vs-Asian |
1.095630E-01 |
AfricanAmerican-vs-Asian |
3.791700E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
1.27620003453899E-09 |
Normal-vs-Female |
1.26639998487832E-09 |
Male-vs-Female |
5.976600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
1.86629999998633E-06 |
Normal-vs-Age(41-60Yrs) |
2.73419999974323E-07 |
Normal-vs-Age(61-80Yrs) |
3.4771963086655E-11 |
Normal-vs-Age(81-100Yrs) |
1.032530E-04 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.835410E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.603800E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.071000E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.962160E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.058400E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.061600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
2.876600E-01 |
Normal-vs-Grade 2 |
1.62650999999681E-05 |
Normal-vs-Grade 3 |
2.66969779616488E-11 |
Normal-vs-Grade 4 |
1.62991842245219E-12 |
Grade 1-vs-Grade 2 |
2.437000E-01 |
Grade 1-vs-Grade 3 |
2.349700E-02 |
Grade 1-vs-Grade 4 |
1.201740E-04 |
Grade 2-vs-Grade 3 |
2.301800E-02 |
Grade 2-vs-Grade 4 |
4.57099999962018E-07 |
Grade 3-vs-Grade 4 |
1.778630E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
3.201200E-04 |
Normal-vs-ccB subtype |
2.43720044146301E-10 |
ccA subtype-vs-ccB subtype |
2.156300E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
2.74070000028104E-08 |
Normal-vs-N1 |
2.207200E-04 |
N0-vs-N1 |
3.537800E-01 |
|
|